Literature DB >> 962332

Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation.

J L Rogge, J M Hanifin.   

Abstract

Various reports have indicated assorted immune defects in atopic dermatitis, but the prevalence and degree of the defects remain unclear. We assessed various immunological factors in 14 patients with atopic dermatitis to determine whether immunodeficiencies were present consistently and were reflected by the patients' clinical characteristics. A high incidence of cutaneous infection was noted. Cutaneous delayed-hypersensitivity testing showed anergy in eight (67%) patients. Only the seven patients with the most severe condition showed altered leukocyte function, as determined by polymorphonuclear and mononuclear leukocyte chemotaxis and by lymphocyte responsiveness to phytohemaglutinin. All three cell types where shown to be simultaneously dysfunctional during severe atopic flares. Chemotactic studies during clinical remissions disclosed notable improvement in cell migration. Serum IgE levels were elevated in each patient, but did not correlate with the degree of cutaneous anergy or altered leukocyte function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 962332

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  18 in total

1.  Lymphocyte suppressor activity in atopic eczema.

Authors:  B E Ogden; G G Krueger; H R Hill
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 2.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

3.  In vivo and in vitro effects of glucocorticoids on lectin-induced blastogenesis in atopic dermatitis.

Authors:  M Rupprecht; R Rupprecht; N Wodarz; H U Braner; J Kornhuber; H U Koch; P Riederer; O P Hornstein
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

4.  Immunoglobulin E anti-Candida antibodies and candidiasis.

Authors:  S Mathur; J M Goust; E O Horger; H H Fudenberg
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

5.  Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis.

Authors:  T Jakob; B N Huspith; Y E Latchman; R Rycroft; J Brostoff
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

6.  Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.

Authors:  H H Kesarwala; R V Prasad; R Szep; E Oldman; S Lane; P S Papageorgiou
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

7.  Immunoglobulin E anti-Staphylococcus aureus antibodies in atopic patients.

Authors:  G A Walsh; K L Richards; S D Douglas; M N Blumenthal
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

8.  Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis.

Authors:  T Ternowitz; T Herlin
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

9.  Impaired monocyte-mediated cytotoxicity in atopic dermatitis.

Authors:  K Kragballe; T Herlin; J R Jensen
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

10.  Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors.

Authors:  B E Ogden; H R Hill
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.